Title: Reducing APOE4 in carriers is a therapeutic goal for Alzheimer Disease: Report of the APOE4 National Institute on Aging (NIA) /Alzheimer Disease Sequencing Project (ADSP) Consortium Working Group

Documenti analoghi

• Influence of ancestry in mitochondrial processes in APOE4 carriers of Alzheimer's Disease
  di: Katrina Celis, et al.
  Pubblicazione: (2025)
• APOE ε4 genotype confers risk for Alzheimer Disease in Cuban Americans
  di: Jose Javier Sanchez, et al.
  Pubblicazione: (2024)
• The DAWN Alzheimer's Research Study: A multi‐site collaboration with enriched AD phenotype clinical data for the Alzheimer's Disease Sequencing Project‐ADSP
  di: Pedro R Mena, et al.
  Pubblicazione: (2025)
• Report of the APOE4 National Institute on Aging/Alzheimer Disease Sequencing Project Consortium Working Group: Reducing APOE4 in Carriers is a Therapeutic Goal for Alzheimer's Disease
  di: Jeffery M. Vance, et al.
  Pubblicazione: (2024)
• APOE *4 and Cell‐Type‐specific Risk‐Modifying Genes in Alzheimer’s Disease
  di: Youjie Zeng, et al.
  Pubblicazione: (2025)